Novavax Catches Up to Competitors With FDA Approval for Updated COVID-19 Boosters

Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a recombinant version of the virus’ spike protein to elicit protection.